New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:12 EDTHRTXHeron Therapeutics reports Q4 EPS (75c), consensus (53c)
The company said "Net loss was higher in the FY13 quarter primarily due to increased spending related to manufacturing development expenses and higher personnel costs, including stock compensation expense."
News For HRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 20, 2015
10:00 EDTHRTXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:32 EDTHRTXHeron Therapeutics resumed with a Buy at Jefferies
Subscribe for More Information
March 19, 2015
09:20 EDTHRTXOn The Fly: Pre-market Movers
Subscribe for More Information
08:06 EDTHRTXHeron: Anesthetic effects of HTX-011 persisted through 96 hours in Phase 1 trial
Subscribe for More Information
March 13, 2015
08:04 EDTHRTXHeron Therapeutics reports Q4 EPS (71c), consensus (79c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use